PDS Planning Inc Increases Stake in Intuitive Surgical, Inc. $ISRG

PDS Planning Inc boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 42.5% during the 2nd quarter, Holdings Channel reports. The fund owned 2,264 shares of the medical equipment provider’s stock after acquiring an additional 675 shares during the quarter. PDS Planning Inc’s holdings in Intuitive Surgical were worth $1,230,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the company. Nuveen LLC acquired a new position in shares of Intuitive Surgical during the first quarter worth $1,715,899,000. Goldman Sachs Group Inc. lifted its holdings in Intuitive Surgical by 26.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock worth $1,396,496,000 after buying an additional 584,375 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Intuitive Surgical by 20.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock worth $1,680,922,000 after buying an additional 566,979 shares during the last quarter. Wellington Management Group LLP lifted its holdings in Intuitive Surgical by 15.0% during the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after buying an additional 457,080 shares during the last quarter. Finally, Vanguard Group Inc. raised its position in shares of Intuitive Surgical by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after acquiring an additional 453,335 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. BTIG Research restated a “buy” rating and issued a $571.00 target price on shares of Intuitive Surgical in a report on Wednesday, October 1st. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a report on Wednesday. Erste Group Bank reissued a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Finally, Evercore ISI cut their target price on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating on the stock in a research report on Tuesday. Fourteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $589.43.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $429.59 on Friday. The firm has a fifty day moving average price of $458.68 and a 200 day moving average price of $497.98. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The stock has a market cap of $154.00 billion, a P/E ratio of 59.91, a P/E/G ratio of 4.66 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business’s revenue was up 21.4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.78 earnings per share. Sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In related news, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Amy L. Ladd sold 336 shares of the company’s stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the transaction, the director owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. The trade was a 23.83% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is currently owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.